Literature DB >> 34917246

Novel Indole Compounds as TEAD Inhibitors for Treating Cancer.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34917246      PMCID： PMC8667059          DOI： 10.1021/acsmedchemlett.1c00609

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer.

Authors:  Wenxia Zhao; Mengyan Wang; Meilian Cai; Conghui Zhang; Yuhan Qiu; Xiaowei Wang; Tianshu Zhang; Huimin Zhou; Junxia Wang; Wuli Zhao; Rongguang Shao
Journal:  Biomed Pharmacother       Date:  2020-11-11       Impact factor: 6.529

Review 2.  Trailblazing perspectives on targeting breast cancer stem cells.

Authors:  Juntao Li; Dan Qi; Tze-Chen Hsieh; Jason H Huang; Joseph M Wu; Erxi Wu
Journal:  Pharmacol Ther       Date:  2021-01-07       Impact factor: 12.310

Review 3.  The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis.

Authors:  Mohammad Reza Zinatizadeh; Seyed Rouhollah Miri; Peyman Kheirandish Zarandi; Ghanbar Mahmoodi Chalbatani; Catarina Rapôso; Hamid Reza Mirzaei; Mohammad Esmaeil Akbari; Habibollah Mahmoodzadeh
Journal:  Genes Dis       Date:  2019-12-05

Review 4.  Dynamic EMT: a multi-tool for tumor progression.

Authors:  Simone Brabletz; Harald Schuhwerk; Thomas Brabletz; Marc P Stemmler
Journal:  EMBO J       Date:  2021-08-30       Impact factor: 11.598

Review 5.  The role of Hippo-YAP signaling in squamous cell carcinomas.

Authors:  Tomohiko Maehama; Miki Nishio; Junji Otani; Tak Wah Mak; Akira Suzuki
Journal:  Cancer Sci       Date:  2020-12-09       Impact factor: 6.518
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.